Corrupted proteins in focus: How shape gives rise to variations of fatal brain disease

Scientists have spent decades working to better understand how prions cause these diseases. But new research from the Case Western Reserve University School of Medicine and the National Institutes of Health (NIH) Rocky Mountain Laboratories brings into focus how prions might be formed and how they can result in different disease outcomes.

This collaborative research team discovered a new prion structure through revolutionary new imaging using specialized electron microscopes at the Cleveland Center for Structural and Membrane Biology Cryo-Electron Microscopy Core and the Rocky Mountain Laboratories. The new structure is of a second prion strain, providing an atomic-level view into how corrupted prion proteins self-convert and assemble.

"Prions are unusual pathogens. Different prions result in different disease lengths and symptoms in their host," said Allison Kraus, assistant professor of pathology at the School of Medicine, who co-led the research with Byron Caughey at NIH. "This has long perplexed scientists because different diseases occur with corruption of the same protein from its original shape."

The research was published this month in Nature Communications.

"Our study identifies the key similarities and differences in prions and how these features compare to other types of self-converting proteins," Kraus said. "We can now begin to appreciate how those key similarities and differences shape disease outcomes of prion disease and compare the outcomes to other brain diseases."

Prion disease occurs when prion proteins are refolded, causing a chain reaction where other prion proteins refold and accumulate in the brain, according to the NIH.

Kraus said the new prion imaging could play a key role towards understanding prion disease outcomes.

"Neurodegenerative brain diseases are incredibly complex," she said. "With indications that corrupted shapes do indeed occur with different prion diseases, and with further research into more prion strains, we can begin to understand how specific prion shapes relate to disease outcomes."

Study authors include: Kraus, Heidi Standke, Kunpeng Li, Matteo Manca and Olivia Thomas from Case Western Reserve; and Forrest Hoyt, Efrosini Artikis, Cindi Schwartz, Bryan Hansen, Andrew Hughson, Gregory Raymond, Brent Race, Gerald Baron and Caughey from NIH.